98 related articles for article (PubMed ID: 7851833)
1. [Treatment of obesity as an insulin resistance].
Ohashi M
Fukuoka Igaku Zasshi; 1994 Nov; 85(11):323-5. PubMed ID: 7851833
[TBL] [Abstract][Full Text] [Related]
2. Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.
Rave K; Roggen K; Dellweg S; Heise T; tom Dieck H
Br J Nutr; 2007 Nov; 98(5):929-36. PubMed ID: 17562226
[TBL] [Abstract][Full Text] [Related]
3. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension.
Tekes S; Cikim AS
J Hum Hypertens; 2007 Jul; 21(7):546-50. PubMed ID: 17392814
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Ariza CR; Frati AC; Gómez G; Almazán A
Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
[TBL] [Abstract][Full Text] [Related]
6. [Interconnection between insulin resistance and lipid metabolism disorders in obese patients].
Ageeva VV; Krasil'nikova EI; Zubina IM; Shliakhto EV
Ter Arkh; 2002; 74(10):12-5. PubMed ID: 12469622
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
8. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
9. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children.
Reinehr T; de Sousa G; Andler W
Obes Res; 2005 Oct; 13(10):1824-33. PubMed ID: 16286531
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
13. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
[TBL] [Abstract][Full Text] [Related]
14. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
[TBL] [Abstract][Full Text] [Related]
15. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
16. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
Sindelka G; Skrha J; Hilgertová J; Justová V
Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
[TBL] [Abstract][Full Text] [Related]
17. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
Lind L; Lithell H; Pollare T
J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
[TBL] [Abstract][Full Text] [Related]
18. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
Brun JF; Aloulou I; Varlet-Marie E
Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
[TBL] [Abstract][Full Text] [Related]
19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
20. [Obesity and insulin resistance].
Pandolfi C; Pellegrini L; Sbalzarini G; Mercantini F
Minerva Med; 1994 Apr; 85(4):167-71. PubMed ID: 8028743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
